U.S. stock futures are edging mostly higher as investors watch corporate earnings, Honeywell plans to split into three companies, and Qualcomm stock drops as its licensing revenue misses expectations.

US stocks were mixed on Thursday in anticipation of Amazon's quarterly results, as investors assessed the earnings season so ...

Eli Lilly's strong momentum in blockbuster therapies and promising pipeline signals future growth, but competition and ...

Eli Lilly’s profit doubled in the fourth quarter, propelled by its hot-selling diabetes and obesity treatments, and the ...

Weight loss drugs are huge these days, and Eli Lilly (LLY) is leading the pack when it comes to these. However, today’s ...

The results were consistent with the preliminary results Eli Lilly shared in January, which disappointed investors.

Analysts on Wall Street project that Qualcomm (QCOM) will announce quarterly earnings of $2.93 per share in its forthcoming report, representing an increase of 6.6% year over year. Revenues are ...

Below is Validea's guru fundamental report for QUALCOMM INC (QCOM). Of the 22 guru strategies we follow, QCOM rates highest using our P/E/Growth Investor model based on the published strategy of ...

Eli Lilly has invested heavily into obesity, dominating the landscape—alongside semaglutide maker Novo Nordisk—with its ...

We recently published a list of Coatue’s 35 Most Important AI Stocks. In this article, we are going to take a look at where QUALCOMM Incorporated (NASDAQ:QCOM) stands against Coatue’s other most ...

Eli Lilly stock is higher Thursday after the pharma giant beat fourth-quarter profit expectations and issued strong 2025 ...

Eli Lilly reported mixed fourth-quarter results on Thursday, surpassing earnings expectations but falling short of sales projections, even as demand for its flagship weight loss drug Zepbound and ...